Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease
- Substances:Napazimone
Germany- Participants:18–64 years · 65+ years
- Substances:Napazimone
- Sponsor:Pharming Technologies B.V.
Rare diseases
Investigational molecules
Locations
Back to Germany408 clinical trials in Dessau-Roßlau, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
GermanyStudy on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)
GermanyStudy on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma
GermanyStudy of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy
GermanyStudy of Tersolisib and a drug combination for adults with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
GermanyFirst-line treatment of metastatic non‑small cell lung cancer with high PD‑L1 expression: ivonescimab versus pembrolizumab
GermanyLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
GermanyA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
GermanyA Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer
GermanyStudy on the Effectiveness of Green Tea Leaf Extract Ointment for Adults with Actinic Keratosis on the Scalp and Face
GermanyStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
GermanyPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on breast cancer treatments, including trials for HER2-positive, hormone receptor-positive, and triple-negative variants. Research includes novel combination therapies and targeted treatments.
Notable investigations into pre-operative and post-resection treatments for various cancer types.
Innovative research addressing cardiovascular disease and cholesterol management, with trials evaluating new treatments for reducing cardiovascular events and managing lipid levels.
Focus on developing new therapeutic approaches for cardiovascular health improvement.
Clinical investigations of treatments for severe skin conditions, particularly focusing on hidradenitis suppurativa and other inflammatory skin disorders.
Evaluation of novel therapeutic agents for chronic skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.